Anti-SLC35D1 monoclonal antibody

Pre-made anti-SLC35D1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SLC35D1/SLC35D1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1711-Ab-1/ GM-Tg-hg-IP1711-Ab-2Anti-Human SLC35D1 monoclonal antibodyHuman
GM-Tg-rg-IP1711-Ab-1/ GM-Tg-rg-IP1711-Ab-2Anti-Rat SLC35D1 monoclonal antibodyRat
GM-Tg-mg-IP1711-Ab-1/ GM-Tg-mg-IP1711-Ab-2Anti-Mouse SLC35D1 monoclonal antibodyMouse
GM-Tg-cynog-IP1711-Ab-1/ GM-Tg-cynog-IP1711-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC35D1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1711-Ab-1/ GM-Tg-felg-IP1711-Ab-2Anti-Feline SLC35D1 monoclonal antibodyFeline
GM-Tg-cang-IP1711-Ab-1/ GM-Tg-cang-IP1711-Ab-2Anti-Canine SLC35D1 monoclonal antibodyCanine
GM-Tg-bovg-IP1711-Ab-1/ GM-Tg-bovg-IP1711-Ab-2Anti-Bovine SLC35D1 monoclonal antibodyBovine
GM-Tg-equg-IP1711-Ab-1/ GM-Tg-equg-IP1711-Ab-2Anti-Equine SLC35D1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1711-Ab-1/ GM-Tg-hg-IP1711-Ab-2; GM-Tg-rg-IP1711-Ab-1/ GM-Tg-rg-IP1711-Ab-2;
GM-Tg-mg-IP1711-Ab-1/ GM-Tg-mg-IP1711-Ab-2; GM-Tg-cynog-IP1711-Ab-1/ GM-Tg-cynog-IP1711-Ab-2;
GM-Tg-felg-IP1711-Ab-1/ GM-Tg-felg-IP1711-Ab-2; GM-Tg-cang-IP1711-Ab-1/ GM-Tg-cang-IP1711-Ab-2;
GM-Tg-bovg-IP1711-Ab-1/ GM-Tg-bovg-IP1711-Ab-2; GM-Tg-equg-IP1711-Ab-1/ GM-Tg-equg-IP1711-Ab-2
Products NameAnti-SLC35D1 monoclonal antibody
Formatmab
Target NameSLC35D1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SLC35D1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1711-Ag-1Recombinant multi-species S35D1/ SLC35D1/ SHNKND protein


    Target information

    Target IDGM-IP1711
    Target NameSLC35D1
    Gene ID23169,242585,298280,700175,100685241,101087505,613734
    Gene Symbol and SynonymsC330011J09,mKIAA0260,SHNKND,SLC35D1,SLC35D2,UGTREL7
    Uniprot AccessionQ9NTN3,A2VE55
    Uniprot Entry NameS35D1_HUMAN,S35D2_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000116704
    Target ClassificationN/A

    The target: SLC35D1, gene name: SLC35D1, also named as SHNKND, UGTREL7. Glycosylation of cellular glycoconjugates occurs in the endoplasmic reticulum (ER) and Golgi compartment, and requires transport of nucleotide sugars from the cytosol into the lumen of the ER and Golgi by specific transporters. The protein encoded by this gene resides in the ER, and transports both UDP-glucuronic acid (UDP-GlcA) and UDP-N-acetylgalactosamine (UDP-GalNAc) from the cytoplasm to the ER lumen. It may participate in glucuronidation and/or chondroitin sulfate biosynthesis. Mutations in this gene are associated with Schneckenbecken dysplasia.[provided by RefSeq, Sep 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.